Speaker 1: Nikolaus Dietlein (Rodewald Lab): Towards the role of histone H2B monoubiquitination in the hematopoietic system - Speaker 2: Patrizia Jensen (Scholl/Fr?hling Lab): Identification of potential targets for palbociclib combination therapy in MLL-rearranged AML